Noninvasive Characterization of Indeterminate Pulmonary Nodules Detected on Chest High-Resolution Computed Tomography

Abstract

The widespread implementation of lung cancer screening, following favorable results of the National Lung Screening Trial (NLST) and more recently the European NELSON trial, will likely continue to exacerbate the widespread clinical problem of indeterminate pulmonary nodules, which were detected in 40 percent of high-risk individuals screened by low dose high-resolution computed tomography (HRCT) in the NLST. Because 96 percent of these nodules were benign, the issue of diagnostic resolution of incidentally and screen-identified lung nodules will become increasingly important. Current clinical and radiological risk prediction models, which allow risk-stratification of patients and individualize management of pulmonary nodules, are commonly used, but remain suboptimal, and optimization of the clinical management of larger (greater than or equal 7 mm) screen-detected nodules is urgently needed to avoid unnecessary diagnostic interventions leading to unwarranted mortality, morbidity and healthcare costs. In our project, we explore the utility of a conventional radiomic approach to the classification of screen-detected indeterminate nodules, leveraging unexploited large datasets contained on digital HRCT images to estimate the probability of malignancy based on selected predictive quantitative radiologic features.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2018
Accession Number
AD1094557

Entities

People

  • Fabien Maldonado

Organizations

  • Vanderbilt University Medical Center

Tags

DTIC Thesaurus Topics

  • Application Software
  • Biomedical Research
  • Cancer
  • Cancer Screening
  • Databases
  • Department Of Defense
  • Detection
  • Health Services
  • High Resolution
  • Imaging Techniques
  • Lung Cancer
  • Medical Personnel
  • Morbidity
  • Neoplasms
  • Probability
  • Tomography
  • X-Ray Computed Tomography

Fields of Study

  • Medicine

Readers

  • Economics
  • Oncology and Biomarker-Based Cancer Detection.